We invite you to learn about the Foundation's research grants. The search feature and the table below represent the Foundation's complete research portfolio. You may search the complete list of grants by status (open/active or closed/inactive), research program area, and disease.
If you are interested in a specific research program area, browse the recently funded research by program area.
To browse active grants you may also wish to view the 2020 Grants Portfolio publication.
Filter for Grant pages
Keyword Search for Grant pages
Research Program Area
|02534: Clinical Trial for Evaluation of Propranolol and Doxorubicin in the Treatment of Canine Hemangiosarcoma||University of Minnesota||Erin B. Dickerson, PhD and Brian Husbands, DVM||Open||Oncology - Hemangiosarcoma|
|02595-A: Defining the Flow Cytometric Characteristics of Normal and Diseased Canine Spleen and Visceral Lymph Nodes||University of Minnesota||Courtney E. Johnson, DVM||Open||Oncology|
|02643-A: Examination of the Effects of Cannabidiol on Canine Neoplastic Cell Apoptosis/Autophagy and Potential for Chemotherapy Resistance or Sensitivity||Cornell University||Joseph J. Wakshlag, DVM, PhD||Open||Oncology|
|02642-A: NF-kappaB Inactivation Enhances Apoptosis in Canine Osteosarcoma Cells||University of Georgia||Travis Laver, VMD, PhD||Open||Oncology - Osteosarcoma|
|02663: Comparative Brain Tumor Consortium (CBTC) Meningioma Pathology Board||National Institutes of Health/National Cancer Institute/Center for Cancer Research/Comparative Oncology Program, Cornell University, and University of Pennsylvania||Amy LeBlanc, DVM, Andrew Miller, DVM and Molly Church, MS, VMD, PhD||Open||Oncology|
|02636-A: Development of RNA in-situ Hybridization to Identify T Regulatory Cells and their Function within the Tumor Microenvironment of Canine Oral Malignant Melanoma||University of Florida||Sandra M. Bechtel, DVM||Open||Oncology|
|2489: Tumor-permissive Collagen Signatures in Canine Mammary Gland Tumors: Development of Prognostic Markers and Targeted Therapies for Improved Outcomes||University of Pennsylvania||Susan W. Volk, VMD, PhD||Open||Oncology|
|02502: Precision Medicine for Canine Lymphoma||Trustees of the University of Pennsylvania||Nicola J Mason, BVetMed, PhD||Open||Oncology - Lymphoma|
|02510-T: Identification of Novel Synthetic Lethal Partners to Optimize PI3K Targeted Therapies in Canine Hemangiosarcoma||Tufts University School of Medicine||Cheryl A. London, DVM, PhD||Open||Oncology - Hemangiosarcoma|
|02487: OX40 Checkpoint Molecule Targeted Antibodies for Cancer Immunotherapy in Dogs||Colorado State University||Steven W. Dow, DVM, PhD||Open||Oncology|
|02519: Prevalence of Bartonella spp. Infection in Dogs with Cardiac and Splenic Hemangiosarcomas within and between Geographic Locations||North Carolina State University||Edward B Breitschwerdt, DVM; Matthew Breen, PhD||Open||Oncology - Hemangiosarcoma|
|02500: Immune Targeting of the V600E B-Raf Neoantigen in Canine Urothelial Carcinoma||University of Pennsylvania||Nicola J Mason, BVetMed, PhD||Open||Oncology|
|02456-A: The Impact of Intravenous Anesthetic Agents on Canine Natural Killer Cell||Trustees of the University of Pennsylvania||Oliver A Garden, BVetMed, PhD||Open||Oncology|
|02321: Clinical Trial of Procaspase-3 Activator (PAC-1) in Combination with Hydroxyurea for Treatment of Canine Meningioma||University of Illinois||Timothy M. Fan, DVM, PhD||Open||Oncology|
|02317: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B cell Lymphoma||North Carolina State University||Matthew Breen, PhD||Open||Oncology - Lymphoma|
|2309-T: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma||University of Missouri||Angela McCleary-Wheeler, DVM, PhD||Open||Oncology - Lymphoma|
|02316: Genetic Risk Factors for Canine T zone Lymphoma||Colorado State University||Anne A. Avery, DVM, PhD||Open||Oncology - Lymphoma|
|02234-MOU: A Novel Approach for Prevention of Canine Hemangiosarcoma||University of Minnesota||Jaime F Modiano, VMD, PhD||Open||Oncology - Hemangiosarcoma|
|01660: Identifying the Genes That Confer Risk for Osteosarcoma||The Research Institute at Nationwide Children's Hospital||Carlos E. Alvarez, PhD||Open||Oncology - Osteosarcoma|
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.